About

Fostering cross-disciplinary collaboration

Led by Infection, Immunity and Cancer (IIC) researchers Professor Alyssa Barry and Professor Eugene Athan, CIIDIR will foster cross-disciplinary collaboration to conduct innovative, locally relevant and internationally important research. This work will enhance the prevention, control and treatment of some of our most challenging infectious diseases like staphylococcal infections, COVID-19 and Buruli ulcer and immune-mediated diseases such as food allergies, asthma and childhood-onset diabetes).

Find out more

Research Pillars

Molecular Microbiology

Fundamental research on host-pathogen and medical device interactions to uncover biological pathways that are critical for infection and inflammation.

Immunity and Inflammation

Basic and translational research on immunity and inflammation, and microbial diversity (pathogens and microbiome) to inform vaccine and biomarker development and therapeutic interventions.

Population Health and Biology

Epidemiology and surveillance to understand patterns of disease and disease transmission in human populations, and development of innovative approaches for surveillance.

Clinical and Public Health Research

Clinical studies of infectious disease and immune disorders. Including implementation and operational research on public health interventions.

Twitter Feed

Today is #WorldMSDay! Join us as we stand in solidarity with the global MS community. 🌎 Together we are advocating for early and accurate diagnosis for everyone living with MS. Support the #MyMSDiagnosis campaign today: https://worldmsday.org/take-action/

Daptomycin is an essential tool for combating infections with S. aureus. What contributes to high-level daptomycin resistance? Research in @mSphereJ points to a lipid biosynthesis gene, pgsA, which influences membrane fluidity & cell wall thickness. https://asm.social/1Tl

2 weeks until #CDIC2024!
Join us in Brisbane and learn to empower health & protect communities through #DiseaseControl & #Immunisation.
Register now: http://www.cdic2024.com/registration

“Prevalence (of secondary infections) was highest in the Pre-Delta (10.4%) & Omicron BA2 (8.1%) periods”
An unprecedented comprehensive analysis of secondary infections among patients admitted with COVID-19 in Victoria.

https://www.sciencedirect.com/science/article/pii/S1201971224001498#abs0001

Load More

Latest News & Events

Future Science Talks – Comedy Edition

  Please come join me at Future Science Talks: Comedy Edition, as part of the Melbourne International Comedy Festival.   I will be giving a 10-minute talk at Science Gallery Melbourne that’s 80% science and 20% humour.   The ticket link is here, and there are early-bird discounts!   Looking forward to seeing you at

Molecular Approaches to Malaria 2024

Photo of Barry lab members attending MAM 2024. Sachintha Wijegunasekara, Dulcie Lautu, Paolo Bareng, Jasmin Akter, Alyssa Barry Katelyn Stanhope, Zahra Razook, Charles Narh, Myo Naung (Kirsty McCann not present in photo).      In February 2024 members of the Barry Lab attended Molecular Approaches to Malaria 2024 (MAM2024) conference. This conference occurs every 4

2023 Barwon Health Research Symposium

  The 2023 Barwon Health Research Symposium was held on the 28th of November to celebrate 2023’s year in research. The symposium included presentations by established and emerging Barwon Health researchers, presentations by Best Paper of the Year finalists, an exhibition of research posters and the awarding of the 2023 Barwon Health Deakin University Research

Subscribe to our newsletter

Stay up to date on the latest news and events from CIIDIR.